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Anrep effect; Na ϩ /H ϩ exchanger; SFR IN 1912, VON ANREP DESCRIBED that immediately after cardiac outflow is clamped the heart dilates, tending to return to its initial volume after that (34) . He concluded that the decrease in blood flow to the adrenal glands induced the release of catecholamines producing a positive inotropic effect. However, subsequent investigations reported the same phenomenon in isolated hearts after the depletion of catecholamine stores (27, 28) . Sarnoff et al. (28) coined the term "homeometric autoregulation" to characterize the Anrep effect. In 1973, Parmley and Chuck (24) reproduced this phenomenon in myocardial strips. Allen and Kurihara in 1982 (3) and Kentish and Wrzocek in 1998 (20) provided an explanation for the increase in contractility that fully develops after 10 -15 min of stretch by showing a progressive increase in Ca 2ϩ transient without changes in myofilament Ca 2ϩ responsiveness during this period. This second phase of increased force after myocardial stretch was later termed the "slow force response" (SFR) to stretch in contrast to the abrupt and immediate increase in force after stretch mediated by changes in myofilament Ca 2ϩ responsiveness (for review, see Refs. 12, 15) .
Based on early activation of the cardiac Na ϩ /H ϩ exchanger (NHE-1) after stretch (2, 9), we proposed a stretch-triggered chain of events that begins with the release of angiotensin II (ANG II)/endothelin (ET) from myocardial cells and ends with an increase in Ca 2ϩ transient through the Na ϩ /Ca 2ϩ exchanger (NCX) favored by the NHE-1-mediated increase in intracellular Na ϩ (2, 7, 10 -12, 26) . However, the crucial role of NHE-1 in determining the Anrep effect has been challenged by several contradictory results. First, Kondratev et al. in 2005 (22) reported that the inhibition of NHE-1 with cariporide abolished stretch-induced calcium, but not sodium, accumulation in mouse ventricular muscle. Second, Ward et al. in 2008 (36) working also in mice, proposed that stretch-activated channels (SAC), not NHE-1, were involved in the mechanism underlying SFR development. In addition, the pharmacological compounds previously used to inhibit NHE-1 and abolish the SFR might have other nonspecific actions than inhibiting sarcolemmal NHE-1 (16, 33) .
Silencing myocardial NHE-1 by small interference RNA [small hairpin (sh)RNA] emerges as a suitable tool to specifically prevent the effects of NHE-1 hyperactivity without affecting other organ tissues. Interestingly, growing evidence indicates that shRNA may exert cell-to-cell effects not only in plants and nematodes but also in mammalian cells (31) . In this regard, Kizana et al. (21) recently drew attention to the fact that gene transferring to tissues bearing gap junctions can exert cell-to-cell effects along the syncytium through specific connexins. Furthermore, it was recently reported (17) a successful in vivo whole heart protein silencing after three left ventricular wall injections of a lentiviral vector in mice, using a technique similar to the one used herein. All this evidence encouraged us to attempt the direct intramyocardial injection of a lentiviral vector coding for shRNA against NHE-1 (l-shNHE1) in the rat left ventricular wall as a way to induce efficient and stable knock down of NHE-1 protein in the ventricular syncytium, a condition that would permit clarifying the precise role of NHE-1 in the SFR to stretch.
MATERIALS AND METHODS
All procedures followed during this investigation conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and were approved by the Animal Welfare Committee of La Plata School of Medicine.
Construction and production of lentiviral vectors. A third generation lentiviral vector capable of expressing a reporter gene under the CMV promoter and shRNA under the RNA polymerase III H1 promoter was produced as previously described (4, 7) . Briefly, the shRNA against the NHE-1 was subcloned into a third generation lentiviral vector plasmid that expresses DsRed under the CMV promoter and shRNA under the RNA polymerase III H1 promoter (PPT.C.DsRed.H1). The shRNA sequence against NHE-1 was constructed inserting 5=-GATAGGTTTCCATGTGATC-3= (positive strand), followed by 5=-GTTCTTCAAGAGAGAAC-3= (loop), 5=-ATCACATGGAAACCTATC-3= (negative strand), and 5=-ATCA-CATGGAAACCTATC-3= (terminator), at the BamHI cloning site (5=) and PacI cloning site (3=), following the H1 RNA polymerase promoter, to generate PPT.C.DsRed.H1.shNHE1 (l-shNHE1). This shRNA against NHE-1 was previously proven effective in reducing whole NHE1 protein expression in cultured fibroblasts (1) . Moreover, based on nucleotide sequence alignment (multiple sequence alignment, ClustalW), this sequence specifically targets NHE1 mRNA from human, rat, or mouse origin and has low percentage chance of recognizing a different mRNA other than NHE1 (Basic Local Alignment Search, Blast-NCBI; E value 0.035). For viral vector production, HEK293T cells were plated in T75-cm 2 flasks to obtain 80 -90% confluency on the day of transfection and cotransfected with a four plasmid vector system using Lipofectamine 2000 (Invitrogen). The crude viral suspension was harvested from 293T cell cultures 48 and 72 h after transfection, filtered (0.2 m), and concentrated using Centricon Plus-70 filter columns (100,000 molecular weight cut-off; Millipore) at 70,000 g at 8°C for 2 h (4). Vector aliquots were subsequently stored at Ϫ80°C until use. Vector titers were determined measuring fluorescence of positive HEK293 cells, transduced with serial viral dilutions in 293T cells, in the presence of 10 g/ml of polybrene (Sigma). The same lentiviral vector coding for a disorganized nonsilencing nucleotide sequence (scramble) was used as a control.
Intramyocardial injection of the lentivirus vector. Four-to fivemonth-old male Wistar rats were anesthetized with sevofluorane (ϳ4% for induction and 2-3% for maintenance) used in a gas mixture with oxygen and delivered through ventilation by using a positivepressure respirator (model 680; Harvard, South Natick, MA). After deep anesthesia was reached, a left thoracotomy was performed via the fourth intercostal space, with the lungs retracted to expose the heart. Following this, the l-shNHE1 or the scramble lentivirus (ϳ2ϫ10 7 transducing units in 200 l volume, multiplicity of infection of ϳ80) were intramyocardially injected at two sites in the free wall of the left ventricle, close to the cardiac apex, using a 30-G needle (4). After injection, the lungs were inflated by increasing positive endexpiratory pressure, and the thoracotomy site was closed in layers. Immediately after surgery, rats were returned to their cages and carried to a recovery room and subsequently returned to the animal facility until death (1 mo later). Rats had ad libitum access to food and water.
Determination of NHE-1 protein expression. Rat heart membranes were prepared from freshly isolated left ventricles 1 mo of lentiviral injection. The myocardium was homogenized with a Brinkmann Homogenizer (Brinkmann Instruments, Westbury, NY) in ice-cold homogenization buffer containing 0.32 M sucrose, 1 mM EGTA, 0.1 mM EDTA, 10 mM HEPES (pH 7.5), and protease inhibitors (MiniComplete tablets, Roche). Homogenates were centrifuged at 1,440 g for 5 min in a Beckman G5-6K centrifuge. Supernatants were removed and centrifuged at 66,700 g for 30 min at 4°C in a Beckman TLA 100.4 rotor. The resulting membrane fraction was resuspended in 300 l of PBS containing the following (in mM): 140 NaCl, 3 KCl, 6.5 Na 2HPO4, and 1.5 KH2PO4, pH 7.5. Protein was quantified by fluorometry using the Qubit fluorometer, and 100 g of protein were used for immunoblots. For immunodetection, protein samples were resolved by SDS-PAGE on 8% acrylamide gels, transferred to polyvinylidene fluoride membranes, and then incubated with mouse anti-NHE1 (MAB3140, 1:2000; Chemicon) or rabbit anti-Na ϩ /K ϩ -ATPase (sc-28800; 1:1000; Santa Cruz). Immunoblots were then incubated with 1:1,000 dilution of donkey anti-rabbit IgG (sc-2317; Santa Cruz) or donkey anti-mouse IgG (sc-2314; Santa Cruz), conjugated to horseradish peroxidase. Blots were visualized with enhanced chemiluminescence reagent (ECL; Millipore) and a Chemidoc Station (Bio-Rad) and quantified using Image-J analysis software.
Isolated papillary muscles. Isolated papillary muscles were used to assess the SFR to stretch as previously done (26) . Briefly, the muscles were mounted in a perfusion chamber placed on the stage of an inverted microscope (Olympus) and bathed with a CO 2/HCO3 Ϫ -buffered solution containing the following (in mmol/l): 128.3 NaCl, 4.5 KCl, 1.35 CaCl 2, 20.23 NaHCO3, 1.05 MgSO4, and 11.0 glucose, and equilibrated with 5% CO2-95% O2 (pH ϳ7.40). The possible participation of cathecholamines released by the nerve endings was prevented by adrenergic receptors blockade with 1.0 mol/l prazosin plus 1.0 mol/l atenolol. The muscles were paced at 0.2 Hz at a voltage 10% over threshold and maintained at 30°C, and isometric contractions were recorded. Cross-sectional area (calculated as 0.75 of the product of thickness by width) was used to normalize force records obtained with a silicon strain gauge (model AEM 801; SensoNor). Two papillary muscles per rat were dissected. The slack length of each muscle was determined after mounting, and subse- Fig. 1 . A: schematic representation of the procedure followed to inject the lentivirus into the left ventricular wall. B: hearts injected with lentiviral vector (l-shNHE1) designed to specifically downregulate Na ϩ /H ϩ exchanger (NHE-1) expression showed a significant reduction in the exchanger protein compared with the scramble-injected hearts as shown in the original western blot and in the averaged results (each sample was run by duplicate). *P Ͻ 0.05, scramble vs. l-shNHE1. quently they were progressively stretched to the length at which they developed maximal twitch force (Lmax). Then, the muscles were shortened to 92% of the length at which they exerted maximal developed force (L92) and maintained at this length until the beginning of the experimental protocol, when they were abruptly stretched to L98 (98% of the length at which they exerted maximal developed force).
Measurement of pH i and determination of NHE-1 activity. pHi was measured in isolated left ventricular papillary muscles using a previously described BCECF-epifluorescence technique (25) . NHE-1 activity was assessed by the pH i recovery from an ammonium prepulseinduced acute acid load (8) . The experiments were performed in the nominal absence of bicarbonate (HEPES buffer) to assure that pHi recovery after the acidic load was entirely due to NHE-1 activation. The papillary muscles were acid loaded by transient (10 min) exposure to 30.0 mmol/l NH 4Cl followed by washout with Na ϩ -containing HEPES buffer. This technique allows promoting a profound intracellular acidification to activate the NHE-1. Briefly, after addition of NH 4Cl to the medium an immediate alkalinization occurs due to the rapid, passive entry of NH3 and its subsequent hydration to form NH4 ϩ and OH Ϫ . Since the membrane exhibits certain permeability to NH4 ϩ as well, this results in an influx of this ion early during the exposure to NH4C1. Such an influx tempers the alkalinization due to NH3 influx, since a small fraction of these ions dissociate to form H ϩ and NH3. Thus, even when pHi is still rising, some H ϩ would be carried into the cell by the incoming NH4 ϩ , which is also responsible of the spontaneous pHi decrease that occurs during sustained NH4Cl exposure. Sudden removal of external NH4
ϩ results in an exit of NH3 and NH4
ϩ . However, since the driving force for net efflux of NH4 ϩ is less than for the previous influx of these ions (due to the effect of membrane potential), the cell loses fewer NH 4 ϩ than it has gained. Therefore, withdrawal of NH4CI from the medium determines a fall in pHi to lower values than before exposure. The peak of acidification occurs after ϳ1 min of NH4CI washout and then pHi starts to recover toward control values. In the present study, the recovery of pHi was monitored during 30 min. The rate of pHi recovery (dpHi/dt) at any selected pHi value during the recovery phase was calculated as the derivative of the exponential fit of pHi vs. time records at the specified pHi value. Maximal NHE-1-mediated H ϩ efflux (JHϩ) was calculated in both groups at the beginning of the recovery phase from acidosis by multiplying the maxdpHi/dt to the corresponding calculated intrinsic buffer capacity (␤i).
Myocardial DsRed fluorescence. Samples of the apex, base, and papillary muscles were obtained from a set of l-shNHE1-injected and Fig. 2 . Representative confocal images of l-shNHE1-injected (top) and sham-operated (bottom) rat hearts. Samples of the apex, base, and papillary muscles were serially sectioned using a vibratome and incubated with DAPI. On the first column, the presence of nuclei is evidenced by DAPI staining. Second column shows the DsRed fluorescence. Every l-shNHE1-injected heart analyzed (n ϭ 3) showed greater intensity of red fluorescence in the apex compared with the base and papillary muscle. Third column is a contrast phase of the sample being observed. Fourth column shows the merge of first and second columns. Bar for all samples ϭ 10 m.
sham operated hearts (n ϭ 3 both groups) 1 mo after surgery. Myocardial tissue was fixed in phosphate-buffered formaldehyde 4%, pH 7.4 during 24 h. Then, samples were serially cut into 10-m thick sections using a vibratome (Leica VT 1000S). Mounted slices were incubated for 15 min with the fluorescent DNA stain DAPI. Fluorescence was detected using a confocal microscope (Olympus FV1000) with a U-MWG2 excitation filter (510 -550 nm) for DsRed detection and U-MWU2 (330 -385 nm) for DAPI detection. Solid state lasers 559 and 405 were used for excitation of DsRed and DAPI fluorophores, respectively. An objective of ϫ40 (UPlanSAPO) with a NA of 0.95 and a ϫ3 zoom was used. For capturing the images, the intensity of the laser 559 and of its photomultiplier were kept constant to qualitatively compare the samples.
Statistics. Data are expressed as means Ϯ SE. Student t-test or one-way ANOVA followed by Student-Newman-Keuls test when appropriate were used to compare data. Two-way ANOVA was used to compare poststretch force data in scramble and l-shNHE1-injected papillary muscles. A P value Ͻ 0.05 was considered of statistical significance.
RESULTS
NHE-1 expression in the rat ventricular myocardium was measured 1 mo after injection of the l-shNHE1, which was designed to specifically downregulate NHE-1. Figure 1A shows a schematic representation of the procedure followed to inject the lentivirus into the width of the left ventricular wall. Hearts injected with l-shNHE1 had an ϳ55% reduction in NHE-1 protein expression compared with the scramble-injected ones (P Ͻ 0.05; Fig. 1B ). This result suggested us that the siRNA against the NHE-1 had spread from the sites of injection throughout the ventricular myocardium. Importantly, the lack of effects of the l-shNHE1 on other sarcolemmal protein expressions like the NCX [scramble: 100 Ϯ 9% (n ϭ 3) and l-shNHE1 96 Ϯ 9% (n ϭ 4)] or the Na ϩ /K ϩ ATPase [scramble: 100 Ϯ 14% (n ϭ 3) and l-shNHE1 107 Ϯ 19% (n ϭ 3)] suggests that the l-shNHE1 specifically targeted the NHE-1. To check the spreading of the lentivirus we measured DsRed fluorescence in the apex, base, and papillary muscles of a group of l-shNHE1-injected and sham operated rats. As expected, red fluorescence was observed in the myocardium of the lentivirus-injected hearts while no signal was detected in the sham operated Wistar rats. Figure 2 shows representative images obtained from one l-shNHE1-injected and one sham operated heart.
The function of NHE-1 was assessed in papillary muscles isolated from l-shNHE1 and scramble-injected hearts by com- Fig. 3 . Recovery from an acidic load was dramatically impaired in papillary muscles from l-shNHE1-injected hearts compared with scramble. A: representative pHi traces obtained during the ammonium prepulse and the recovery phase in both groups of papillary muscles. B: averaged results of the maximal (initial) rate of pHi recovery (dpHi/dtmax). In addition to the depressed rate of recovery from acidosis, muscles injected with l-shNHE1 showed a significantly magnified maximal ammonium-induced intracellular acidification (C) and lower basal pHi (D). E: comparison between groups of H ϩ efflux (JHϩ) at common pHi values during the recovery from the acidic load, revealing a significantly smaller JHϩ in muscles from l-shNHE1-injected hearts than in those from scramble ones, reflecting the effect of NHE-1 silencing. *P Ͻ 0.05, scramble vs. l-shNHE-1. Fig. 4 . A: original force record of a papillary muscle from a scramble-injected (scramble) rat heart subjected to an increase in length from 92 to 98% of the length at which they exerted maximal developed force (L92 to L98), where it can be appreciated the classical biphasic response to stretch. B: same as in A but of a papillary muscle from a l-shNHE1-injected rat heart, where the SFR was suppressed. C: averaged slow force response (SFR) expressed as percentage of the initial rapid phase from both groups of animals. *P Ͻ 0.05, scramble vs. l-shNHE1. paring the rate of pH i recovery from an ammonium prepulseinduced acidic load. The experiments were performed in the nominal absence of bicarbonate to exclude the participation of a bicarbonate-dependent mechanism. Recovery from the acidic load was impaired in papillary muscles from l-shNHE1-injected hearts compared with scramble-injected hearts (Fig. 3A) , which is reflected in the lower maximal dpH i /dt in the formers (Fig. 3B) . Interestingly, in addition to the diminished velocity of recovery from acidosis, muscles injected with l-shNHE1 had a magnified maximal ammonium-induced intracellular acidification of ϳ0.11 pH i units and a significantly lower basal pH i of ϳ0.14 pH i units (Fig. 3, C and D) . The decrease in basal pH i under conditions in which the only active pH i regulatory mechanism is the NHE-1 suggests that nonsilenced NHE-1 protein units were not enough to functionally compensate for the background acid loading. The decrease in the recovery velocity after the acidic load (dpH i /dt) at a given pH i is a function of H ϩ efflux (J H ϩ) and the intrinsic buffer capacity of the tissue. The J H ϩ was calculated after correction for the intracellular H ϩ buffering power, 1 which was similar between l-shNHE1-injected and scramble-injected hearts. The relation between J H ϩ and pH i during the recovery from acidosis was shifted to the left in NHE-1-silenced myocardium as shown in Fig. 3E . In other words, at any given pH i , J H ϩ was always smaller in l-shNHE1-injected than in scramble-injected animals, reflecting NHE-1 silencing.
The mechanical response to stretch in l-shNHE1-injected and scramble-injected papillary muscles was then evaluated. Stretching of the papillary muscles from scramble-injected hearts promoted the characteristic biphasic mechanical response: an initial abrupt force increase followed by the SFR, which fully developed after ϳ10 min (Fig. 4, A and C) . On the contrary, the SFR was always absent in papillary muscles isolated from NHE-1-silenced hearts (Fig. 4, B and C) .
Myocardial stretch activates the NHE-1 through posttranslational modifications, mainly phosphorylation, of its cytosolic regulatory domain (14) . We previously reported that myocardial stretch induces NHE-1 phosphorylation at Ser703 (32) through a mechanism that appears to involve a mitochondrialdependent redox-sensitive increase in ERK1/2 and p90 RSK activity (7, 32) . We reasoned that if ERK1/2 activation is upstream NHE-1 phosphorylation, myocardial stretch, through the autocrine/paracrine mechanism, should increase ERK1/2 activity even in NHE-1-silenced myocardium. This was indeed the case, since stretch increased ERK1/2 phosphorylation to approximately the same extent in control and in NHE-1-silenced myocardium as shown in Fig. 5. 1 JH ϭ dpHi/dt ϫ ␤i. 
DISCUSSION
In the present study, a small interference RNA-mediated gene silencing strategy was used to specifically knock down NHE-1 in the myocardium. This technique reduced NHE-1 protein expression to ϳ45% of control and was able to completely cancel the SFR to stretch in rat ventricular myocardium confirming the key role played by the NHE-1 in the SFR to stretch that we previously proposed (2, 7, 10 -12, 26) . It seems it is not necessary to decrease 100% of transporting units in the myocardium to achieve a reduction in Na ϩ transport high enough to suppress the SFR development. The effectiveness of the technique used to silence the NHE-1 seems to be related to the spreading of the l-shNHE1 from cell to cell trough connexins as was proposed by Kizana et al. (21) and successfully practiced by Gupta et al. (17) to silence the NF-B after 7 wk of a lentiviral delivery of shRNA injected directly into the ventricular wall.
The role for NHE-1 in the SFR has been detected in cat (7, 26) , human (35) , rabbit (23) , and rat (2, 6) myocardium. However, due to some contradictory results it remains a matter of controversy. In mouse ventricular myocytes, Kondratev et al. (22) supported that stretch-operated channels and not NHE-1 were responsible for the stretch-induced increase in Na ϩ since cariporide, under their experimental conditions, failed to prevent the rise in Na ϩ but canceled the increase in Ca 2ϩ after stretch. Similarly, the involvement of stretch-operated channels in the stretch response in mouse ventricular muscle was recently proposed by Ward et al. (36) . These investigators were unable to inhibit the SFR using NHE-1 inhibitors. Stretch-operated channels allow either Ca 2ϩ or Na ϩ entry that would permit a direct increase in Ca 2ϩ transient or a Na ϩ -dependent NCX-mediated Ca 2ϩ increase that may conceivably explain the SFR. A role for stretch-operated channels, in addition to NHE-1 activation, had been previously suggested by Calaghan and White in 2004 (6) . However, the pharmacological strategy used to inhibit these channels was challenged based on the possible actions of the inhibitors used on the NCX (38) . Moreover, even though the existence of these stretchoperated channels in the myocardium has been shown by studies recording whole cell currents in isolated cells (5, 13, 18, 19, 29) , single channel studies have never been performed in adult ventricular myocytes (37) , presumptively due to their restriction to T tubules. Recently, transient receptor potential canonical channels were shown to be sensitive to stretch (36) and ANG II (30) .
The fact that contradictory results were obtained in mice opens the question of whether species differences could explain these differences in the mechanisms involved in the SFR development. Another possibility to be analyzed is the participation of transient receptor potential canonical channels in the autocrine/paracrine signaling trigger by stretch upstream ANG II release. Experiments are in progress to analyze both possibilities.
Silencing myocardial NHE-1 by small interference RNA appears as a precious tool to specifically prevent stretchinduced NHE-1 activation without affecting other mechanisms potentially involved in SFR development to clarify their respective roles. Figure 6 schematizes the proposed signaling pathway leading to the SFR development. We proposed that myocardial stretch triggers an autocrine/paracrine mechanism that involves ANG II/ET-mediated mitochondrial ROS production that activates the redox-sensitive ERK1/2. These kinases stimulate NHE-1 activity by promoting the phosphorylation of its regulatory cytosolic tail. NHE-1 hyperactivity increases intracellular Na ϩ concentration favoring NCX reverse mode. The latter induces the rise in intracellular Ca 2ϩ responsible for the SFR development.
Finally, considering the possible impact of our present findings in pathophysiology, we could speculate about a potential therapeutic use of this technique in the clinical practice. In this regard, although NHE-1 hyperactivity appears to be a crucial factor in cardiac hypertrophy and heart failure, treatment of these pathologies with NHE-1 inhibitors is challenging because drugs recognized to be beneficial in experimental models were associated with undesired side effects in the clinical arena. In this scenario, an interference RNA to silence the NHE-1 would be a therapeutic strategy to consider either for patients in class IV of heart failure or even as a bridge to heart transplantation. 
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